Date post: | 14-Dec-2015 |
Category: |
Documents |
Upload: | yasmin-carmon |
View: | 217 times |
Download: | 2 times |
1
Cryotherapy, Brachytherapy Cryotherapy, Brachytherapy & Photodynamic Therapie& Photodynamic Therapie
R EberhardtR Eberhardt
Thoraxklinik am Universitätsklinikum HeidelbergThoraxklinik am Universitätsklinikum HeidelbergInternistische Onkologie der Thoraxtumoren - ThoraxchirurgieInternistische Onkologie der Thoraxtumoren - Thoraxchirurgie
R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
International Bronchoscopy Course/Istanbul 2006
2R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Thoraxklinik Heidelberg gGmbH
1885 tuberculosis hospital1885 tuberculosis hospitalsince 1972 rebuild as a clinic forsince 1972 rebuild as a clinic forlung and thoracic diseaseslung and thoracic diseases
3R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
► 4.000 – 5.000 procedures/year
► all interventional procedures
► Endobronchial Ultrasound
► Thoracoscopy in LA
Thoraxklinik Heidelberg gGmbH
4R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
..
Photodynamic therapyPhotodynamic therapy
5R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
..
based on the dye-sensitized photooxidation of based on the dye-sensitized photooxidation of biological matter in the target tissue/tumorbiological matter in the target tissue/tumor
ligthligth photosensitizerphotosensitizer oxygenoxygen
the light and the chemical interaction leads to the light and the chemical interaction leads to necrosis of the tumornecrosis of the tumor
PDT: photodynamic therapyPDT: photodynamic therapy
6R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
..
ideal photosensitizerideal photosensitizer
► high uptake in malignant tumorshigh uptake in malignant tumors► low uptake in benign tissuelow uptake in benign tissue► low phototoxicitylow phototoxicity► safe profilesafe profile► effective cytotoxicity at appropiate effective cytotoxicity at appropiate
wavelengthwavelength► stable and easy to prepare and to stable and easy to prepare and to
administrateadministrate
7R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
..
PhotofrinPhotofrin®®
• porfimer sodium
• the only one on market
• dosification:• Photofrin®® 2 mg/kg
• wash out 48 h
• tumor-to-normal tissue ratio is maximal at 24-48 hours
• illumination 100-800 mW (400mW/cm length of diffuser for 500 sec.)
Photodynamic therapy - PDT
8R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
..
sensitizer concentrationsensitizer concentration
► drug is cleared from the most organs within 72 drug is cleared from the most organs within 72 hourshours
► it is retained in malignant cells it is retained in malignant cells andand skin skin
► concentration depends on concentration depends on : :
► sensitizersensitizer ► tumortumor► timetime
9R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photofrin®
..
Absorption spectrum Absorption spectrum
► peak absorption atpeak absorption ata wavelength of 405 nma wavelength of 405 nm
► light (405nm) completelylight (405nm) completelyabsorbed at the tissue surfaceabsorbed at the tissue surface
► using wavelength of 630 nmusing wavelength of 630 nm
► penetration depth of penetration depth of 5-10 mm can be achieved5-10 mm can be achieved
Wavelength (nm)
10R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
..
11stst stepstep: i.v.-injec: i.v.-injecttiioonn
22ndnd stepstep: : illuminationillumination
33rdrd stepstep: : cytotoxic effectscytotoxic effects
PDT: photodynamic therapyPDT: photodynamic therapy
11R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
..
IlluminationIllumination
to activate the sensitizer at the target tissue
Photodynamic therapy - PDT
12R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Wilson 1986, Dougherty 1991
..
IlluminationIllumination
absorption and diffusion depend on:
• tissue• liver: poor penetration• brain: high penetration
• photosensitizer
Photodynamic therapy - PDT
13R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
..
IlluminationIllumination
Photodynamic therapy - PDT
14R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
..
IlluminationIllumination
microlens fibresfor small tumors and carcinoma in situ
Photodynamic therapy - PDT
15R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
..
IlluminationIllumination
interstitial diffusing fibresfor big and obstructive tumors
Photodynamic therapy - PDT
16R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
..
► time of illuminationtime of illumination 5- 30 minutes5- 30 minutes
► Clean up-BronchoscopyClean up-Bronchoscopy after 1-3 Tageafter 1-3 Tage
► 2. PDT during 2-7 days possible2. PDT during 2-7 days possible
PDT: photodynamic therapyPDT: photodynamic therapy
17R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
..
18R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
..
19R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
..
Photodynamic therapyPhotodynamic therapy
Indications are visible malignant tumors for:
• cure
• palliation
20R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Data Photodynamic therapy - PDT
* not visible in CT-Scan / **modified to Sutedja T 1996* not visible in CT-Scan / **modified to Sutedja T 1996
Occult lung cancer* Occult lung cancer* ** Lesions Results
CR (%)Survival Month
Monnier et al., 1990 16 69 3-60
Okunaka et al., 1991 27 98 38
Edell and Cortese, 1992
14 71 7-49
Furuse et al., 1993 59 83 14-32
Inamura et al., 1994 39 64 4-169
Sutedja et al., 1994 39 72 2-95
Cortese et al., 1997 21 53 12
21R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Data Photodynamic therapy - PDT
Hayata Y et al. Lasers Med Sci 1996Hayata Y et al. Lasers Med Sci 1996
PDT – Early CancerPDT – Early Cancermaximal extent lesions CR (%)
superficial type (123 lesions, 110 patients)
< 0,5 cm 64 61 (95)
< 1 cm 25 22 (88)
< 2,0 cm 20 9 (45)
> 2,0 cm 14 6 (43)
nodular type (45 lesions, 43 patients)
< 0,5 cm 29 27 (93)
< 1,0 cm 9 6 (67)
> 1,0 cm 7 1 (14)
22R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
..
Photodynamic TherapyPhotodynamic Therapyresults (145 Pat., 191 tumors)
Stadium 0 99
Stadium IA 56
Squamos cell carcinoma 98%
CR 86%
Tumor size < 1 cm* 95%
Tumor size ≥ 2 cm 46%
Distal end visible+ 92%
Distal end not visible 67%
*/+ 98%
Recurences 13%
Long term response 75%
Mathur PN et al. Chest 2003; 123:176S-180S
23
Early CancerEarly Cancer
R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
EBUS – Early Cancer
24
Early CancerEarly Cancer
R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
EBUS – Early Cancer
25R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
EBUS – Early Cancer
Miyazu Y et al., Am J Respir Crit Care Med, 2002
26R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
EBUS – Early Cancer
Miyazu Y et al., Am J Respir Crit Care Med, 2002
27R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
data Photodynamic therapy - PDT
..
alternative to surgical alternative to surgical resectionresection
well tolerated und cost-well tolerated und cost-effectiveffectiv
potentially curative potentially curative treatmenttreatment
28R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
Carrol et al. Eur J Cancer Clin Oncol 1986;22:1352-56Carrol et al. Eur J Cancer Clin Oncol 1986;22:1352-56
Ernst et al. Respir Crit Care Med 2004; 169: 1278-1297Ernst et al. Respir Crit Care Med 2004; 169: 1278-1297
..
► 57% 57% of the patients with non surgical tumors and of the patients with non surgical tumors and 36% 36% of of total will total will die for local problemsdie for local problems
► 20-30% of patients with lung cancer will develope 20-30% of patients with lung cancer will develope CAO and up to 40% of lung cancer deaths may be CAO and up to 40% of lung cancer deaths may be attributed tp locoregional diseaseattributed tp locoregional disease
PDT: for palliativePDT: for palliative
29R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
12 articles, 636 patients12 articles, 636 patients indication: severe bronchial obstructionindication: severe bronchial obstruction histology: mostly NSCLChistology: mostly NSCLC symptom relief: almost all patients (> 90%) symptom relief: almost all patients (> 90%) main complication: sunburn (- 28%)main complication: sunburn (- 28%) fatal complication: haemoptysis (< 3%)fatal complication: haemoptysis (< 3%) PDT is safe and effectivePDT is safe and effective
Advanced stage lung cancerAdvanced stage lung cancer
Moghissi K, Dixon K; Eur Respir J 2003; 22: 535-541.Moghissi K, Dixon K; Eur Respir J 2003; 22: 535-541.
30R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
Lam et al; Proc Spie Proc 1991: pp20-28Lam et al; Proc Spie Proc 1991: pp20-28
..
RadiotRadiothheraperapyy versus PDT versus PDT
► 41 patients41 patients► pdt+rdt: repermeabilization: 70% of pat.pdt+rdt: repermeabilization: 70% of pat.► rdt only: repermeabilization: 10% of pat.rdt only: repermeabilization: 10% of pat.► no response: 20% of pat.no response: 20% of pat.
PDT: for palliativePDT: for palliative
31R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
Diaz-Jimenez JP et al. Eur Respir J 1999; 14(4): 800-5Diaz-Jimenez JP et al. Eur Respir J 1999; 14(4): 800-5
..
31 patients31 patients
► airway obstruction >75% in 77,4%airway obstruction >75% in 77,4%
► 14 PDT 14 PDT ► 17 ND-YAG-Laser resection17 ND-YAG-Laser resection
PDT versus Nd-YAG-LaserPDT versus Nd-YAG-Laser
32R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
Diaz-Jimenez JP et al. Eur Respir J 1999; 14(4): 800-5Diaz-Jimenez JP et al. Eur Respir J 1999; 14(4): 800-5
..
► effectiveness similiareffectiveness similiar► safety comparablesafety comparable► Nd:YAG Nd:YAG
better initial responsebetter initial response faster reobstruction faster reobstruction
► PDT PDT longer time until treatment failurelonger time until treatment failure longer medial survival (295 : 95 days)longer medial survival (295 : 95 days) but: differences in tumor stage between the groupsbut: differences in tumor stage between the groups
PDT versus Nd-YAG-LaserPDT versus Nd-YAG-Laser
33R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
..
IndicationsIndications
• dysplasia: no formal indication
• carcinoma in situ: prior
• microinvasive carcinoma : optional
• invasive carcinoma : palliative
34R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
..
LimitationsLimitations
• size and location of tumor
• 48h waiting after injection
• 2-3 days for tumoral necrosis
• phototoxicity
35R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
..
ContraindicationsContraindications
specifics:previous pneumonectomyinvasion of big vesselsbilateral obstructión main carina
general:porfiria or porfirin allergyleucos < 2.000platelets < 100.000 TP > 1,5 of normal
36R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
Moghissi K, Dixon K; Eur Respir J 2003; 22: 535-541.Moghissi K, Dixon K; Eur Respir J 2003; 22: 535-541.
ComplicationsComplications
• dyspnea*• worsening obstruction*• fever 20%• massive haemorrhage 2,2%• minors 0,5%• sun light photosensitivity 5-28%
* usually resolved after clean-upbronchoscopy
37R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Photodynamic therapy - PDT
..
EstimationEstimation• effectiv in relatively non invasive, limited and effectiv in relatively non invasive, limited and superficial lesions with visible margins superficial lesions with visible margins
• suitable in: suitable in: • Carcinoma in situCarcinoma in situ• microinvasive cancermicroinvasive cancer• severe dysplasiasevere dysplasia
• clear indication in inoperable patientsclear indication in inoperable patients
• debatetable as first-line, when surgery is debatetable as first-line, when surgery is refusedrefused
38R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Brachytherapy
..
BrachytherapyBrachytherapy
IridiumIridium192192 HDR HDR endobronchial irradiationendobronchial irradiation
39R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Brachytherapy
..
BrachytherapyBrachytherapy
high dose rate (HDR) = > 2 Gy/min
Iridium192 half-life = 74,5 days
dose 15 – 47 Gy (messured in 10mm)
1– 5 sessions
duration 1 – 10 min
1 cm
30
Gy
7.5
Gy
3.3
Gy
3cm
40R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Brachytherapy
American Brachytherapy Society Brachytherapy for Carcinoma of the Lung, Oncology 2001
..
Enforcement Enforcement
dose (HDR) palliative intent (10mm):
only Brachytherapy: 4 x 6 Gy or 3 x 7,5 Gy or 2 x 10 Gy
Brachytherapy for Boost: 4 x 4 Gy or 3 x 5 Gy or 2 x 7,5 Gy
> sufficient distance between probe and tissue
> radiation > 2cm over proximal and distal end
41R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Brachytherapy
..
42R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Brachytherapy
..
blind-tipped catheterblind-tipped catheter
After After loading loading techniquetechnique
43R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
data Brachytherapy
Chella-A et al, Lung Cancer 2000
Nd-YAG vs. Nd-YAG+Brachytherapie
• N = 29 randomized/NSCLC Nd-YAG
Nd-YAG + EBBT p
N 15 14
FEV1 (ml) + 810 + 890 n.s.
Stenosis (Speiser‘s index) - 3,4 - 4,2 n.s.
Survival (month) 7,4 10,3 n.s.
Time to progression (month) 2,2 7,5<0,0
5
Numbers of interventional treatments (n) 15 3 <0,0
5
44R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
data Brachytherapy
External Radiation +/- Brachytherapy 2x 4,8 Gy -
randomized•
p = 0.42 p = 0.007
survival . time to progression
Huber-RM et al, Int J Radiation Oncology Biol Phys 1997
45R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
data Brachytherapy
Brachytherapie – Early cancer
Author Year modus n follow up[Jahre]
CR Rezidiv
Edell 1990 PDT 21 2 71% 48%
Edell 1993 PDT 58 5 84% 39%
Imamura 1994 PDT 29 2 64% 36%
Lam 1998 PDT 102 5 78% 44%
Tredaniel 1994 EBBT 29 2
Perol 1997 EBBT 19 1 83% 25%
Marsiglia 2000 EBBT 34 2 85% 35%
46R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
PDT plus Brachytherapy
Freitag L, Ernst A, Thomas M, Prenzel R, Wahlers B, Macha HNFreitag L, Ernst A, Thomas M, Prenzel R, Wahlers B, Macha HNThorax 2004; 59:790-793Thorax 2004; 59:790-793
..
Sequential photodynamic therapy (PDT) and high dose Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in brachytherapy for endobronchial tumour control in
patients with limited bronchogenic carcinomapatients with limited bronchogenic carcinoma
PDT PDT 2 mg/kg Photofrin® i.v.
HDR-BrachytherapieHDR-Brachytherapieafter 5 – 6 weeksIridium 192 - 4 Gy weekly up to 20 Gy
Follow UpFollow UpBronchoscopy every 3 month
47R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
PDT plus Brachytherapy
..
PDTPDT• CR 75 %
Brachytherapy Brachytherapy • 31/32 Pat. without histological proof of tumor
• response rate 97 % • recurrence in 6/32 (19 %)• than lokal therapy or external radiation allowed
Follow Up Follow Up • all patients are living after 24 month (3-46 all patients are living after 24 month (3-46 month )month )Freitag L, Ernst A, Thomas M, Prenzel R, Wahlers B, Macha HNFreitag L, Ernst A, Thomas M, Prenzel R, Wahlers B, Macha HN
Thorax 2004; 59:790-793Thorax 2004; 59:790-793
..
48R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
PDT plus Brachytherapy
..
• results are surprisingly goodresults are surprisingly good
• long time survival and tumor controll seems to long time survival and tumor controll seems to bebe better than PDT or EBBT alone better than PDT or EBBT alone
• no severe complicationsno severe complications
• prospective randomized study necessaryprospective randomized study necessaryFreitag L, Ernst A, Thomas M, Prenzel R, Wahlers B, Macha HNFreitag L, Ernst A, Thomas M, Prenzel R, Wahlers B, Macha HNThorax 2004; 59:790-793Thorax 2004; 59:790-793
..
Sequential photodynamic therapy (PDT) and high Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic control in patients with limited bronchogenic
carcinomacarcinoma
49R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Brachytherapy
..
Complications Complications
• acute bronchitis
• fistula
• stenosis
• fatal/letal hemorhaghe• up to 42 %• risk factors:
• infiltration of the big vessels• upper Lobe• external beam radiation prior
50R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Brachytherapy
..
BrachytherapyBrachytherapy
• Endoluminal and intramural tumorsEndoluminal and intramural tumors
• Complementary to other endoscopic Complementary to other endoscopic treatmentstreatments
• local long time response local long time response
• Possible after ERTPossible after ERT
• Outpatient basisOutpatient basis
51R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Brachytherapy
..
BrachytherapyBrachytherapy
• Delayed effect (weeks)Delayed effect (weeks)
• Several sessionsSeveral sessions
• No emergenciesNo emergencies
• ExpensiveExpensive
52R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Cryotherapy
..
CryotherapyCryotherapy
53R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Cryotherapy
..
CryotherapyCryotherapy
► Liquid nitrous oxide NLiquid nitrous oxide N22O (-80O (-8000C)C)
► Ice ball (-40Ice ball (-4000C)C)
► flexible/rigid probeflexible/rigid probe
► tissue freezingtissue freezing► selective cellular necrosisselective cellular necrosis► elimination of vascularizationelimination of vascularization
54R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Cryotherapy
..
CryotherapyCryotherapy
physical effectphysical effect immediateimmediate freezing and recrystallization freezing and recrystallization
of water on thawingof water on thawing celluar dehydrationcelluar dehydration
vascular effectvascular effect results in tissue ischemia results in tissue ischemia
from vasoconstrictionfrom vasoconstriction platelet aggregationplatelet aggregation increased blood viscosityincreased blood viscosity
55R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Cryotherapy
Joule-Thompson effectJoule-Thompson effect
Cryo-probeCryo-probe
high pressure
atmosphericpressurecooling
effect
56R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Cryotherapy
..
CryoprobeCryoprobe
57R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Cryotherapy
..
The effects of freeze injury depend on the
► rate of freezing and rewarming
► effect depends on rapidity of freezing and thawingeffect depends on rapidity of freezing and thawing rapid coolingrapid cooling slow thawingslow thawing
► the lowest temperature achievedthe lowest temperature achieved
► number of sessionsnumber of sessions
► cryosensitivity of the tissue (water content)
58R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Cryotherapy
..
cryosensitive cryosensitive cryorestistantcryorestistant
► skin► mucous
membranes► nerve cells► granulation tissue► vascular
endothelium
► nerve sheats► fibrous tissue► connective tissue► cartilage► fat tissue
59R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Cryotherapy
..
How to do it ...How to do it ...
CryoproCryoprobebe
IceballIceball
60R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Cryotherapy
..
How to do it ...How to do it ...
• Cryoprobe Cryoprobe
o IceballIceball
61R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Cryotherapy
..
IndicationsIndications
► AblationAblation malignant tumorsmalignant tumors benigne tumorsbenigne tumors stent-over-growthstent-over-growth
► curable intent in early lung cancer curable intent in early lung cancer
► bleedingbleeding
► foreign bodysforeign bodys
► recanalizationrecanalization immediately ?immediately ?
62R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Cryotherapy
Cryotherapy in advanced Cryotherapy in advanced bronchial carcinomabronchial carcinoma
► 33 patients/81 sessions33 patients/81 sessions improvement in lung function 58%improvement in lung function 58% relief of bronchial obstruction 77%relief of bronchial obstruction 77%Walsh DA et al. Thorax 1990Walsh DA et al. Thorax 1990
► 172 patients/344 sessions172 patients/344 sessions improvement in dyspnoe 50,5%improvement in dyspnoe 50,5% 10% increase in Karnofsky index all over10% increase in Karnofsky index all overAsimakopoulus G Chest 2005Asimakopoulus G Chest 2005
63R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Cryotherapy
Cryotherapy in early superficial Cryotherapy in early superficial bronchogenic carcinomabronchogenic carcinoma
► 35 patients35 patients► 41 cancers41 cancers
► complete response in 91%complete response in 91%► recurrence rate of 28% within 4 yearsrecurrence rate of 28% within 4 years► long term response of 63%long term response of 63%
► results comparable to PDT?? results comparable to PDT??
Deygas N Chest 2001; 120: 26-31Deygas N Chest 2001; 120: 26-31
64R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Cryotherapy
..
RecanalizationRecanalization
65R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Cryotherapy
..
RecanalizationRecanalization
66R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Cryotherapy
Central airway obstruction and respiratory Central airway obstruction and respiratory failurefailure
ContraindicationContraindication
NO NO
CRYO !CRYO !
67R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Cryotherapy
..
AdvantagesAdvantages
► No risk of perforation No risk of perforation
► No risk of firing No risk of firing
► CheapCheap
► Very easy to learnVery easy to learn
contact modecontact mode tactile feed-backtactile feed-back
68R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Cryotherapy
..
Limits and DrawbacksLimits and Drawbacks
► Delayed effect – no emergencies Delayed effect – no emergencies
► Depth of effect is limited – several sessionsDepth of effect is limited – several sessions
► Cannot achieve vaporisation of tissue Cannot achieve vaporisation of tissue
► Coagulation of highly vascularised tissue is notCoagulation of highly vascularised tissue is not achieved as quickly as with the laser or with achieved as quickly as with the laser or with electrocautery electrocautery
► Section of webs (PITS) is impossibleSection of webs (PITS) is impossible
69
Early cancerEarly cancer
R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Data inhomogenous, but ...Data inhomogenous, but ...
if operableif operable resectionresection if not or refusedif not or refused PDTPDT if largerif larger PDT + brachytherapyPDT + brachytherapy alternativesalternatives cryotherapycryotherapy
brachytherapy, brachytherapy, electrocauteryelectrocautery
International Bronchoscopy Course/Istanbul 2006
70R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
central airway obstruction
..
immediate effectimmediate effect• Laser ResectionLaser Resection• ElectrocauteryElectrocautery• Argon Plasma CoagulationArgon Plasma Coagulation• Cryotherapy?Cryotherapy?
delayed effectdelayed effect• BrachytherapyBrachytherapy• Photodynamic therapyPhotodynamic therapy• CryotherapyCryotherapy
advanced lung canceradvanced lung cancer
71R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
central airway obstruction
..
LaserLaser
APCAPC
BrachytheraBrachytherapypy
CryotherapyCryotherapy
PDTPDT
StentsStents
+ 0 +++ 0 ++
++ 0 ++++ 0 ++
0 +++ ++0 +++ ++
endoluminal extraluminal endoluminal extraluminal mixedmixed
advanced lung canceradvanced lung cancer
72R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
central airway obstruction
..
advanced lung canceradvanced lung cancer
► no randomized trialsno randomized trials
► the best therpeutic approach will be the best therpeutic approach will be thethe combination of several treatment combination of several treatment approaches approaches
73
Thank you for your attention …Thank you for your attention …
R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
International Bronchoscopy Course/Istanbul 2006
74R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
International Bronchoscopy Course/Istanbul 2006
75R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Cryotherapy
..
Cooling agentsCooling agents
► Chlorofluoracarbons (CFCs) damage the ozone layer
► Carbon dioxide (CO2) CO2 snow obstructs the cryoprobe
► Lliquid nitrogen (LN2)
► Nitrous oxide (NO2) commonest used agent
76
n = 95, unbehandelte Patienten mit NSCLC, Stadium I - IIIB 30 oder 60 Gy perkutan ± 2 x 7,5 Gy endoluminal
randomisiert
Langendijk-JA et al, Radiotherapy and Oncology 2001
Brachytherapie + externe Radiatio
77
PDT und Brachytherapie bei PDT und Brachytherapie bei limitiertem BClimitiertem BC
► zwischen 4/95 und 11/98 32 Patientenzwischen 4/95 und 11/98 32 Patienten► mit mit
► primärem inoperablen Bronchialkarzinom (n=15) primärem inoperablen Bronchialkarzinom (n=15) ► oder einem Rezidiv (n=17)oder einem Rezidiv (n=17)► begrenzt auf zentrale Atemwegebegrenzt auf zentrale Atemwege
CT und CT und Bronchoskopie mit Weißlicht und Autofluoreszenz sowieBronchoskopie mit Weißlicht und Autofluoreszenz sowie Biopsien vom Tumor und den GrenzenBiopsien vom Tumor und den Grenzen
► Ausdehnung nach Länge, Weite und Erhabenheit über Ausdehnung nach Länge, Weite und Erhabenheit über die Oberflächedie Oberfläche
► histologisch ganz überwiegend Plattenepithelkarzinome histologisch ganz überwiegend Plattenepithelkarzinome (30 von 32)(30 von 32)
78R Eberhardt Pneumologie Thoraxklinik Heidelberg gGmbH
Brachytherapy
..